Assess the clinical disease-modifying effects of one peptide test item given twice-weekly for 3 weeks relative to sham control and vehicle in the relapsing-remitting experimental autoimmune encephalom (2022-2024)
Experts
Emeritus Professor
Maree Smith
Affiliate of Centre for Innovation in Pain and Health Research (CIPHeR)
